Galatea Bio Inc.

We had the privilege of attending the Oxford Nanopore Technologies London Calling meeting, where we joined important discussions on genomic equity and the need for diversity in research.

Next stop: ESHG 2025 in Milan. See you there!

#OxfordNanopore #PrecisionMedicine

A new era in genetic testing has arrived.

Now launching StrataRisk™
globenewswire.com/news-release/2…

#ACMG

#Miamithyroidoncologysymposium

We’re excited to be part of #PMWC2025 —Our session: “Powering Discoveries in Medicine by Pairing Genetic Diversity with AI-enabled Data Analytics” is part of Track B and will be delivered by our CEO, Carlos D. Bustamante on February 7th at 10:15am PT.

lnkd.in/dk2yvMDy